DK0537622T3 - Et antifungalt middel, dets fremstilling og mikroorganismer dertil - Google Patents

Et antifungalt middel, dets fremstilling og mikroorganismer dertil

Info

Publication number
DK0537622T3
DK0537622T3 DK92117183.1T DK92117183T DK0537622T3 DK 0537622 T3 DK0537622 T3 DK 0537622T3 DK 92117183 T DK92117183 T DK 92117183T DK 0537622 T3 DK0537622 T3 DK 0537622T3
Authority
DK
Denmark
Prior art keywords
microorganisms
preparation
antifungal agent
xanthofulvin
eupenicillium
Prior art date
Application number
DK92117183.1T
Other languages
English (en)
Inventor
Toru Okuda
Miyako Masubuchi
Hisao Shimada
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Application granted granted Critical
Publication of DK0537622T3 publication Critical patent/DK0537622T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D311/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/78Ring systems having three or more relevant rings
    • C07D311/80Dibenzopyrans; Hydrogenated dibenzopyrans
    • C07D311/82Xanthenes
    • C07D311/84Xanthenes with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 9
    • C07D311/86Oxygen atoms, e.g. xanthones
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10Antimycotics
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00Chemistry: molecular biology and microbiology
    • Y10S435/8215Microorganisms
    • Y10S435/911Microorganisms using fungi
    • Y10S435/933Penicillium

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Communicable Diseases (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pyrane Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DK92117183.1T 1991-10-09 1992-10-08 Et antifungalt middel, dets fremstilling og mikroorganismer dertil DK0537622T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP91117164 1991-10-09

Publications (1)

Publication Number Publication Date
DK0537622T3 true DK0537622T3 (da) 1998-03-09

Family

ID=8207248

Family Applications (1)

Application Number Title Priority Date Filing Date
DK92117183.1T DK0537622T3 (da) 1991-10-09 1992-10-08 Et antifungalt middel, dets fremstilling og mikroorganismer dertil

Country Status (13)

Country Link
US (2) US5229123A (da)
EP (1) EP0537622B1 (da)
JP (1) JPH0791284B2 (da)
CN (1) CN1071952A (da)
AT (1) ATE156126T1 (da)
AU (1) AU656028B2 (da)
CA (1) CA2079309A1 (da)
DE (1) DE69221251T2 (da)
DK (1) DK0537622T3 (da)
ES (1) ES2106809T3 (da)
GR (1) GR3024925T3 (da)
NZ (1) NZ244604A (da)
ZA (1) ZA927606B (da)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5858350A (en) 1993-12-01 1999-01-12 Marine Polymer Technologies Methods and compositions for poly-β-1→4-N-acetylglucosamine cell therapy system
US5635493A (en) * 1993-12-01 1997-06-03 Marine Polymer Technologies, Inc. Methods and compositions for poly-β-1-4-N-acetylglucosamine chemotherapeutics
US5686115A (en) * 1993-12-01 1997-11-11 Marine Polymer Technologies, Inc. Poly-β-1→4-N-acetylucosamine copolymer composition with collagen
US5622834A (en) * 1993-12-01 1997-04-22 Marine Polymer Technologies, Inc. Method of isolating poly-β-1-4-N-acetylglucosamine from microalgal culture
US5624679A (en) * 1993-12-01 1997-04-29 Marine Polymer Technologies, Inc. Methods and compositions for poly-β-1-4-N-acetylglucosamine biological barriers
US6063911A (en) * 1993-12-01 2000-05-16 Marine Polymer Technologies, Inc. Methods and compositions for treatment of cell proliferative disorders
US5846952A (en) * 1993-12-01 1998-12-08 Marine Polymer Technologies, Inc. Methods and compositions for poly-β-1-4-N-acetylglucosamine drug delivery
US6743783B1 (en) * 1993-12-01 2004-06-01 Marine Polymer Technologies, Inc. Pharmaceutical compositions comprising poly-β-1→4-N-acetylglucosamine
US5789387A (en) * 1995-08-28 1998-08-04 Shaman Pharmaceitucals, Inc. Methods and compositions for treating fungal infections in mammals
US5824545A (en) 1995-11-01 1998-10-20 Millennium Pharaceuticals, Inc. Identification of eukaryotic growth-related genes and promoter isolation vector and method of use
US5888757A (en) * 1996-05-03 1999-03-30 Millennium Pharmaceuticals, Inc. Cell wall assay
JP4975231B2 (ja) * 2000-07-28 2012-07-11 大日本住友製薬株式会社 セマフォリン阻害剤を有効成分とする神経再生促進剤
US7642362B2 (en) * 2002-01-24 2010-01-05 Dainippon Sumitomo Pharma Co., Ltd. Compounds as semaphorin inhibitors
US6917256B2 (en) * 2002-08-20 2005-07-12 Motorola, Inc. Low loss waveguide launch
ES2621018T3 (es) 2007-02-19 2017-06-30 Marine Polymer Technologies, Inc. Composiciones hemostáticas y regímenes terapéuticos
WO2011130646A1 (en) 2010-04-15 2011-10-20 Marine Polymer Technologies, Inc. Anti-bacterial applications of poly -n-acetylglucosamine nanofibers
CN107362171A (zh) 2011-04-15 2017-11-21 海洋聚合物技术公司 用聚‑n‑乙酰基葡糖胺纳米纤维治疗疾病
CN107827805B (zh) * 2017-06-05 2021-01-22 海南师范大学 一种红树植物木果楝真菌来源的吲哚二萜类化合物及其制备方法与应用

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3873714A (en) * 1971-07-14 1975-03-25 Syntex Inc Xanthone carboxylic acids and derivatives

Also Published As

Publication number Publication date
DE69221251D1 (de) 1997-09-04
US5292648A (en) 1994-03-08
EP0537622B1 (en) 1997-07-30
NZ244604A (en) 1995-07-26
AU656028B2 (en) 1995-01-19
AU2623192A (en) 1993-04-22
JPH05239050A (ja) 1993-09-17
ES2106809T3 (es) 1997-11-16
EP0537622A1 (en) 1993-04-21
DE69221251T2 (de) 1998-03-19
CN1071952A (zh) 1993-05-12
GR3024925T3 (en) 1998-01-30
ZA927606B (en) 1993-04-13
US5229123A (en) 1993-07-20
JPH0791284B2 (ja) 1995-10-04
CA2079309A1 (en) 1993-04-10
ATE156126T1 (de) 1997-08-15

Similar Documents

Publication Publication Date Title
DK0537622T3 (da) Et antifungalt middel, dets fremstilling og mikroorganismer dertil
NO307336B1 (no) 2-[(Dihydro)pyrazolyl-3'-oksylmetylen]anilider, anvendelse derav, samt middel inneholdende forbindelsen og mellomprodukter for fremstilling av forbindelsen
DK0559019T3 (da) 14-beta-hydroxy-10-deacetyl-baccatin III og derivater deraf som antitumormidler
ATE4167T1 (de) Derivate der c-076-verbindungen.
FI930977A (fi) Taxanderivat, deras framstaellning och onkologiska anvaendning
FI902710A0 (fi) Pyranylcyanoguanidinderivat.
DE69511424D1 (de) Antifungale sordaridinderivate
PT86785A (pt) Novel naphthalene derivatives having use as antiallergy and antiinflammatory agents
ES2179254T3 (es) 1-poliarilpirazoles plaguicidas.
ES2093037T3 (es) Derivados de beta-lactama y su preparacion.
DK0713702T3 (da) Anxiolytisk middel
ES2110405T3 (es) Un nuevo antibiotico, desoximulundocandina, un procedimiento para su produccion y su uso como medicamento.
GR3020420T3 (en) Alkyl derivatives of trazodone with cns activity.
DK0818464T3 (da) Methylsulfomycin I, fremgangsmåde til dets fremstilling og dets anvendelse
MY103323A (en) Alpha-halopyruvate oxime
ATE127806T1 (de) Antibiotikverbindungen und ihre herstellung.
DK348988A (da) Antibiotikum (fumifungin), mikrobiologisk fremgangsmaade til dets fremstilling samt dets anvendelse
ES2117992T3 (es) Derivados de pirazina.
SU1774617A1 (ru) Производные 3-хлор-1,4-нафтохинона, обладающие бактерицидными и фунгицидными свойствами
SU1455633A1 (ru) О,о-диизопропил-о-[1, 1-диметил-2-пропилтио-2-(о-о-диизопропилфосфорил)- имино]-этилфосфат, обладающий бактерицидной активностью
SU1203863A1 (ru) 6-циклогексил-2-окса-6-азаспиро (3,3) гептан, подавляющий рост сульфатвосстанавливающих бактерий
SU1823451A1 (ru) 2,3а-Дигидрокси-3-(4-толуоил)-3а,4-дигидро-1Н-пирроло[2,1-с][1, 4]бензоксазин-1,4-дион, проявляющий противомикробную активность в отношении кокковых форм бактерий
ATE234927T1 (de) Clavulansäure-dehydrogenase, herstellung und verwendung für die herstellung von clavulansäure
SU1727243A3 (ru) Дезинфицирующее средство